Back to search

United Kingdom· GB-APID-18852711000001100

Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials

A imipenem and cilastatin product containing imipenem + cilastatin, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC J01DH51

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedImipenem 500mg / Cilastatin 500mg pow…ATCJ01DH51REGISTER NO.GB-APID-1885271100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Imipenem and cilastatin is registered in 12 of 19 countries.

Countries holding a registration under ATC J01DH51 (imipenem and cilastatin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Imipenem and cilastatin · ATC J01DH51

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Imipenem + Cilastatin
Manufacturer
Pfizer Ltd
Country
United Kingdom (GB)
ATC code
J01DH51
ATC class
Imipenem and cilastatin
Defined daily dose
2 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    0304090013569
  • gtin
    0304090013576

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for imipenem and cilastatin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Imipenem and cilastatin · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Imipenem and cilastatin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imipenem and cilastatin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Eberth
  • Bulgaria · Имипенем/Циластатин Аптафарма, Мирон
  • Cyprus · Imicilast, Imipenem + Cilastatina Venus Pharma
  • Czechia · Enaros, Imipenem/Cilastatin Aptapharma
  • Germany · Imipenem Cilastatin Panpharma, Imipenem/Cilastatin Basics
  • Denmark · Andatin, Imipenem/Cilastatin Noridem
  • Estonia · Imipenem/Cilastatin Kabi
  • Spain · Enaros, Imipenem/Cilastatina Aurovitas
  • Finland · Andatin, Imipenem/Cilastatin Noridem
  • France · Imipenem Cilastatine Panpharma, Imipenem Cilastatine Sun
  • Greece · Imicil, Imipenem+cilastatin /Kabi
  • Croatia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Hungary · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Ireland · Imipenem/Cilastatin, Imipenem/Cilastatin Hikma Farmacêutica Portugal
  • Italy · Imipenem E Cilastatina Aurobindo, Imipenem E Cilastatina Hikma Farmacêutica
  • Lithuania · Imipenem/Cilastatin Sun, Stinem
  • Latvia · Imipenem/Cilastatin Sun
  • Malta · Imipenem/Cilastatin Aptapharma, Miron
  • Netherlands · Imipenem/Cilastatine Fresenius Kabi, Imipenem/Cilastatine Hikma
  • Norway · Andatin, Imipenem/Cilastatin Fresenius Kabi
  • Poland · Imipenem + Cilastatin Aptapharma, Imipenem + Cilastatin Noridem
  • Portugal · Enaros, Imipenem + Cilastatina Aurovitas
  • Romania · Cilopen, Imipenem/Cilastatin Aptapharma
  • Sweden · Imipenem/Cilastatin Fresenius Kabi, Imipenem/Cilastatin Noridem
  • Slovenia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Slovakia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a072b0eb-2129-47c4-a9c1-0f0ee321a3ca
GET /v1/drugs/a072b0eb-2129-47c4-a9c1-0f0ee321a3ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "18852711000001100",
  "desc": "Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Pfizer Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "4396211000001103",
  "source": "dmd",
  "vtm_id": "775245007",
  "strength": "500 mg",
  "substance": "Imipenem + Cilastatin",
  "ingredient": "Cilastatin sodium",
  "supplier_code": "2082201000001106"
}

See everything about imipenem and cilastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.